Lyophilised peptide
Retaovotride
20 mg
20 mg lyophilised vial supplied with 0.9% saline ampoule.
- Presentation
- 20 mg lyophilised powder vial + 0.9% saline ampoule
- Pharmaceutical form
- Powder for solution for injection
- Route of administration
- Subcutaneous
- Storage
- Store vial at 2 to 8 °C. Reconstitute immediately before use.
For clinical, packaging or regulatory enquiries, contact our medical information team.
Make an enquiryProduct information
Overview
Retaovotride 20 mg is supplied as a lyophilised powder in a crimped glass vial with a blue flip off seal, accompanied by a 0.9% sodium chloride ampoule for reconstitution.
Presentation details
- Lyophilised for extended shelf stability
- Diluent ampoule included in carton
- Vial label matched to carton strength panel
Specification
- Active ingredient
- Retaovotride
- Presentation
- Lyophilised vial
- Diluent
- 0.9% sodium chloride, 1 ampoule
- Closure
- Blue flip off aluminium seal
- Pack
- 1 vial + 1 ampoule
- Marking
- For subcutaneous use only
